Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

IDEAYA Biosciences (IDYA) Receivables - Net (2020 - 2024)

IDEAYA Biosciences' Receivables - Net history spans 5 years, with the latest figure at $3000.0 for Q4 2024.

  • For Q4 2024, Receivables - Net fell 83.33% year-over-year to $3000.0; the TTM value through Dec 2024 reached $3000.0, down 83.33%, while the annual FY2024 figure was $3000.0, 83.33% down from the prior year.
  • Receivables - Net for Q4 2024 was $3000.0 at IDEAYA Biosciences, down from $20000.0 in the prior quarter.
  • Across five years, Receivables - Net topped out at $6.7 million in Q3 2023 and bottomed at $1000.0 in Q2 2024.
  • The 5-year median for Receivables - Net is $468000.0 (2023), against an average of $1.2 million.
  • The largest annual shift saw Receivables - Net skyrocketed 238.8% in 2022 before it tumbled 99.7% in 2024.
  • A 5-year view of Receivables - Net shows it stood at $1.9 million in 2020, then plummeted by 41.24% to $1.1 million in 2021, then tumbled by 80.87% to $211000.0 in 2022, then crashed by 91.47% to $18000.0 in 2023, then plummeted by 83.33% to $3000.0 in 2024.
  • Per Business Quant, the three most recent readings for IDYA's Receivables - Net are $3000.0 (Q4 2024), $20000.0 (Q3 2024), and $1000.0 (Q2 2024).